Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-13T05:04:36.296Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment choice in psychiatry? Would trainees choose similar treatments to those prescribed, and what influences decision-making? A survey of the European Federation of Trainees' (EFPT) Research Group

Published online by Cambridge University Press:  24 June 2014

Sameer Jauhar ,
S. Gerber ,
O. Andlauer ,
J. G. Marques ,
L. Mendonca ,
I. Dumitrescu ,
C. Roventa ,
G. Lydall ,
S. Guloksuz  and
E. Dobrzynska
...Show all authors
Sameer Jauhar
Affiliation:
General Adult Psychiatry, Gartnavel Royal Hospital, Glasgow
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

Surveyraineesdecision-makingefficacyantipsychoticsantidepressantsmood stabilisers
Type
Inpc Young Psychiatrists Programme
Information
Acta Neuropsychiatrica , Volume 21 , Issue S2: Special Issue: Abstracts of 49th Neuropsychiatric Pula Congress, 17-20 June 2009, Pula, Croatia , June 2009 , pp. 64 - 65
Copyright
Copyright © 2009 John Wiley & Sons A/S

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References:

1.Jones, PB, Barnes, TRE, Davies, L, Dunn, G, Lloyd, H, Hayhurst, KP, et al.Randomized Controlled Trial of the Effect on Quality of Life of Second- vs. First-Generation Antipsychotic Drugs in Schizophrenia: Cost Utility of the Latest Antipsy-chotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 2006;63(10):1079–1087.CrossRefGoogle Scholar
2.Lieberman, JA, Stroup, TS, McEvoy, JP, Swartz, MS, Rosenheck, RA, Perkins, DO, et al.Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia. N Engl J Med 2005;353(12):1209–1223.CrossRefGoogle ScholarPubMed
3.Sikich, L, Frazier, JA, McClellan, J, Findling, RL, Vitiello, B, Ritz, L, et al.Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study. Am J Psychiatry 2008;appi.ajp.2008.08050756.CrossRefGoogle ScholarPubMed
4.Leucht, S, Corves, C, Arbter, D, Engel, RR, Li, C, Davis, JM.Second-generation vs. first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009;373(9657):31–41.CrossRefGoogle Scholar
5.Steinert, T. Which neuroleptic would psychiatrists take for themselves or their relatives? Eur Psychiatry 2003;18(1):40–41.CrossRefGoogle ScholarPubMed
6.Bleakley, S, Olofinjana, O, Taylor, D.Which antipsychotics would mental health professionals take themselves? Psychiatr Bull 2007;31(3):94–96.CrossRefGoogle Scholar
7.Taylor, M, Brown, T. “Do unto others as.…”-Which Treatments do Psychiatrists Prefer?. Scottish Medical Journal. 2007;52(1);17–19.CrossRefGoogle Scholar